Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-10000849Phase 2Completed
Phase 2, double-blind trial of iguratimod in rheumatoid arthritis (RA) (2 arms), sponsored by Anhui Medical University. Primary endpoints: Morning stiffness, Pain and 4 more. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-10000849.